Johannes Lässing | Health Professions | Best Researcher Award

Posted on by ScienceFather

Dr. Johannes Lässing | Health Professions | Best Researcher Award

Post doc at Martin Luther University Halle-Wittenberg, Germany

Dr. Johannes Lässing is a distinguished researcher in sports medicine and exercise physiology, currently serving as a research associate and head of sports medicine at Martin Luther University, Halle (Saale). With a Ph.D. (Dr. rer. med.) from the Medical Faculty of Leipzig, awarded magna cum laude, his research focuses on physiological adaptations to exercise, rehabilitation, and preventive healthcare. He has led multiple research projects on chronic metabolic diseases, post-COVID-19 return to sports, and dental protection in athletes. A prolific academic, he has reviewed for top-tier journals such as the European Respiratory Journal and Plos One, further establishing his credibility in the field. Dr. Lässing has also contributed to clinical trials and holds certifications in medical research ethics. His expertise extends to teaching biochemistry, physiology, and pathology in sports. With a strong research foundation, he continues to advance innovative solutions in sports science and rehabilitation.

Professional Profile 

Education

Dr. Johannes Lässing has a strong academic background in sports medicine and rehabilitation. He earned his Dr. rer. med. (Doctor of Medical Science) from the Medical Faculty of Leipzig in February 2022, achieving magna cum laude distinction. His doctoral research focused on the impact of individualized dental protection on cardiopulmonary, hormonal-metabolic parameters, and athletic performance. Prior to his Ph.D., he completed a Master of Science in Rehabilitation and Prevention from 2013 to 2016, further strengthening his expertise in sports medicine and health sciences. His education is complemented by specialized certifications, including advanced and basic courses for clinical investigators under the German Medical Association (AMG), as well as training in study direction for clinical trials. This robust educational foundation, combined with extensive research experience, has equipped Dr. Lässing with the knowledge and skills to contribute significantly to sports medicine, exercise physiology, and preventive healthcare.

Professional Experience

Dr. Johannes Lässing has extensive professional experience in sports medicine and research, currently serving as a research associate and head of sports medicine at Martin Luther University, Halle (Saale), since July 2022. Previously, he was a research associate at the Institute for Sports Medicine and Prevention (2017–2022), where he led multiple projects, including studies on acute physiological adaptations to dental protection, exercise interventions for chronic metabolic diseases, and telemonitoring-based health programs for cancer patients. He also spearheaded research on return-to-sport diagnostics after SARS-CoV-2 infection and strength training adaptations. From 2015 to 2020, he worked as a student and scientific assistant at the same institute, contributing to diabetes research. Additionally, he has served as a lecturer, teaching biochemistry, physiology, anatomy, and pathology in sports science. With expertise in clinical trials and medical diagnostics, Dr. Lässing continues to make significant contributions to exercise physiology and rehabilitation research.

Research Interest

Dr. Johannes Lässing’s research interests lie at the intersection of sports medicine, exercise physiology, and preventive healthcare. His work focuses on understanding the physiological and metabolic adaptations to exercise, with particular emphasis on rehabilitation, chronic disease management, and athletic performance. He has conducted research on exercise interventions for metabolic diseases, post-COVID-19 return-to-sport diagnostics, and the role of dental protection in physiological responses. Additionally, his studies explore the effects of strength training on acute physiological adaptations and the use of telemonitoring for cancer rehabilitation. His expertise extends to clinical trials, where he investigates innovative approaches to improving health outcomes through exercise-based interventions. Dr. Lässing is also interested in biochemistry and pathology in sports, aiming to bridge the gap between medical diagnostics and performance optimization. Through his research, he contributes to advancing knowledge in sports science, rehabilitation strategies, and preventive healthcare applications.

Award and Honor

Dr. Johannes Lässing has been recognized for his contributions to sports medicine and exercise physiology through various academic honors and research grants. He was awarded a prestigious research scholarship (Promotionsstipendium) from the European Social Fund (ESF) between 2017 and 2020, supporting his doctoral research on the impact of individualized dental protection on physiological and metabolic parameters in athletes. His Ph.D. from the Medical Faculty of Leipzig was conferred with magna cum laude distinction, highlighting the excellence of his research. Additionally, his work has been acknowledged through invitations to review for high-impact journals, such as the European Respiratory Journal and Journal of Science and Medicine in Sport. His leadership in multiple research projects at Martin Luther University further demonstrates his academic influence. With his growing impact in sports science and rehabilitation, Dr. Lässing continues to contribute significantly to the advancement of medical research in exercise and preventive healthcare.

Research Skill

Dr. Johannes Lässing possesses a diverse set of research skills in sports medicine, exercise physiology, and clinical trials. His expertise includes designing and leading interdisciplinary research projects focused on physiological adaptations to exercise, rehabilitation, and preventive healthcare. He is proficient in conducting clinical studies, with experience in medical diagnostics, telemonitoring, and self-management programs for chronic diseases and cancer rehabilitation. Dr. Lässing is skilled in data collection and analysis, utilizing advanced physiological and biochemical assessment techniques to study metabolic responses and performance adaptations. His ability to critically evaluate scientific literature is reflected in his role as a reviewer for high-impact journals. Additionally, he has strong teaching and mentorship skills, educating students in biochemistry, physiology, anatomy, and pathology in sports science. With certifications in clinical trial management and medical research ethics, he continues to contribute innovative insights to the field, advancing knowledge in sports science and healthcare interventions.

Conclusion

Johannes Lässing is a strong candidate for the Best Researcher Award based on his extensive contributions to sports medicine and physiology research. His leadership in research projects, publication record, and expertise in clinical trials make him a highly competitive nominee. Strengthening international collaborations, increasing first-author publications, and securing more independent research grants would further elevate his profile.

Publications Top Noted

  • Title: Repetition‐dependent acute cardiopulmonary responses during intensity‐matched squats in males
    Authors: Johannes Lässing, Sonja Hummelmann, Maxi Kramer, Ulrich Laufs, Sven Fikenzer, Roberto Falz
    Year: 2025
    Citation: DOI: 10.1113/EP092363

  • Title: Effects of postoperative physical exercise rehabilitation on cardiorespiratory fitness, functional capacity, and quality of life in patients with colorectal, breast, and prostate cancer – a systematic review and meta-analysis
    Authors: Beyer Mailin, Bischoff Christian, Laessing Johannes, Gockel Ines, Falz Roberto
    Year: 2024
    Citation: DOI: 10.1007/S00432-024-06064-Y

  • Title: Effect of home-based online training and activity feedback on oxygen uptake in patients after surgical cancer therapy: a randomized controlled trial
    Authors: Roberto Falz, Bischoff C, Thieme R, Tegtbur U, Hillemanns P, Stolzenburg JU, Aktas B, Bork U, Weitz J, Lässing J, et al.
    Year: 2023
    Citation: DOI: 10.1186/s12916-023-03010-6

  • Title: Intensity-dependent cardiopulmonary response during and after strength training
    Authors: Lässing J, Maudrich T, Kenville R, Uyar Z, Bischoff C, Sven Fikenzer, Busse M, Roberto Falz
    Year: 2023
    Citation: DOI: 10.1038/s41598-023-33873-x

  • Title: Implantation of an Intraaortic Balloon Pump for Preoperative Cardiogenic Shock SCAI Stages B to C: A Propensity Score–Matched Analysis
    Authors: M. Vondran, K. von Aspern, J. Garbade, M. Schmidt, J. Lässing, T. Ghazy, A. Rastan, M. A. Borger, T. Schröter
    Year: 2022
    Citation: DOI: 10.1055/S-0042-1742844

  • Title: Repeated cardiopulmonary performance measurements in young competitive handball players with and without SARS-CoV-2 infection
    Authors: Johannes Lässing, S. Kwast, C. Bischoff, N. Hölldobler, M. Vondran, R. Falz, M. Busse
    Year: 2022
    Citation: DOI: 10.1186/s13102-022-00591-2

  • Title: Motor control strategies differ between monoarticular and biarticular quadriceps muscles during bipedal squats
    Authors: Tom Maudrich, Tapper P, Clauß M, Roberto Falz, Lässing J, Rouven Kenville
    Year: 2022
    Citation: DOI: 10.1111/sms.14230

  • Title: Effects and duration of exercise-based prehabilitation in surgical therapy of colon and rectal cancer: a systematic review and meta-analysis
    Authors: Roberto Falz, Bischoff C, Thieme R, Dr. Johannes Lässing, Mehdorn M, Stelzner S, Busse M, Gockel I
    Year: 2022
    Citation: DOI: 10.1007/s00432-022-04088-w

  • Title: Is implantable cardioverter defibrillator surgery in patients with an implanted left ventricular assist device safe under uninterrupted oral anticoagulation?
    Authors: Vondran M, von Aspern K, Garbade J, Lässing J, Kiefer P, Rastan AJ, Borger MA, Schroeter T
    Year: 2022
    Citation: DOI: 10.1111/aor.14217

Samy Zaky | Medicine and Dentistry | Best Faculty Award

Posted on by ScienceFather

Prof. Dr. Samy Zaky | Medicine and Dentistry | Best Faculty Award

Hepatogastroenterology and infectious diseases at Al-Azhar University, Egypt

Dr. Samy Zaky El-Sayed Kersh is a distinguished expert in hepatology, gastroenterology, and infectious diseases, with over three decades of experience in clinical practice, research, and education. Serving as Professor Emeritus at Al-Azhar University and holding leadership roles in national health committees, he has significantly contributed to advancing medical science and public health in Egypt. His research is well-recognized, with a ResearchGate h-index of 17 and over 3,785 citations. Dr. Kersh has been actively involved in global collaborations, international conferences, and advanced training programs, enhancing his expertise in cutting-edge techniques like GIT endoscopy and stem cell therapy. A committed educator, he has trained numerous undergraduate and postgraduate students. His membership in prestigious organizations and participation in public health initiatives, such as the COVID-19 Scientific Committee, reflect his dedication to improving healthcare outcomes. Dr. Kersh’s impactful career makes him a leading figure in his field.

Professional Profile 

Education

Dr. Samy Zaky El-Sayed Kersh has a comprehensive and distinguished educational background in medicine, with a focus on tropical medicine, hepatology, and infectious diseases. He earned his M.B.B.Ch. from Al-Azhar University in 1982, followed by a Diploma in General Medicine in 1986 and a Diploma in Pediatric Medicine from Ain Shams University in 1989. He pursued his Master’s degree in Tropical Medicine at Cairo University in 1991 and achieved his M.D. in Tropical Medicine from Al-Azhar University in 1999. Throughout his academic journey, Dr. Kersh has continuously enhanced his knowledge through specialized training and certifications, including intensive care, GIT endoscopy, ultrasonography, and advanced diagnostic techniques. His diverse and multidisciplinary education reflects his commitment to advancing his expertise and addressing complex medical challenges in hepatology, gastroenterology, and infectious diseases, positioning him as a highly knowledgeable and skilled professional in his field.

Professional Experience

Dr. Samy Zaky El-Sayed Kersh boasts a distinguished professional career spanning over three decades in hepatology, gastroenterology, and infectious diseases. He serves as Professor Emeritus at the Faculty of Medicine for Girls, Al-Azhar University, and Head of the Hepatogastroenterology Department at Cairo-Fatiemic Hospital. Dr. Kersh has held leadership positions, including Head of the Infectious Diseases Scientific Committee and member of Egypt’s COVID-19 Scientific Committee under the Ministry of Health. His expertise encompasses advanced diagnostic and therapeutic procedures, such as GIT endoscopy, ultrasonography, and interventions like radiofrequency ablation and stem cell therapy. A committed educator, he has trained countless undergraduate and postgraduate students while contributing to national health initiatives, such as the Viral Hepatitis Prevention Program. Additionally, Dr. Kersh is a sought-after speaker and course director, sharing his knowledge through numerous local and international conferences, making him a prominent figure in medical practice and research.

Research interest

Dr. Samy Zaky El-Sayed Kersh’s research interests lie at the intersection of hepatology, gastroenterology, and infectious diseases, with a focus on advancing diagnostic and therapeutic approaches for liver and gastrointestinal disorders. His work encompasses areas such as the use of ultrasonography and endoscopic techniques for the management of hepatocellular carcinoma, variceal bleeding, and other complications of liver disease. Dr. Kersh has a keen interest in exploring innovative treatments, including stem cell therapy for end-stage liver disease and advanced interventional procedures for gastrointestinal conditions. He is also dedicated to studying the epidemiology and management of infectious diseases, contributing to public health initiatives such as viral hepatitis prevention and COVID-19 response efforts. With numerous publications in reputable journals and active participation in international research collaborations, Dr. Kersh continues to advance medical knowledge and improve clinical outcomes in his specialized fields of interest.

Award and honor

Dr. Samy Zaky El-Sayed Kersh has received numerous awards and honors throughout his illustrious career, reflecting his outstanding contributions to hepatology, gastroenterology, and infectious diseases. He has been recognized both nationally and internationally for his clinical expertise, research innovations, and dedication to medical education. Among his notable achievements, Dr. Kersh has earned CME accreditations from prestigious global organizations, including the American Association for the Study of Liver Diseases (AASLD) and the United European Gastroenterology (UEG). His leadership roles, such as heading the Infectious Diseases Scientific Committee and his involvement in Egypt’s COVID-19 Scientific Committee, further underscore his impact on public health. Additionally, Dr. Kersh’s membership in esteemed professional societies like the European Society of Gastrointestinal Endoscopy and the European Association for the Study of the Liver highlights his standing in the global medical community, marking him as a highly respected and honored medical professional.

Conclusion

Dr. Samy Zaky El-Sayed Kersh exhibits exemplary credentials in academic, clinical, and research domains, making him a strong candidate for the Best Faculty Award. His extensive contributions to medical education, leadership in national health programs, and impactful research align with the criteria of excellence for such an award. Addressing the highlighted areas for improvement could enhance his already impressive profile, further solidifying his candidacy. In summary, Dr. Kersh’s achievements underscore his suitability for the award, and his continued dedication to medical sciences ensures a lasting impact on both the academic and clinical communities.

Publicationstop Noted

  • “Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses”
    Authors: H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, …
    Year: 2022
    Citations: 290
  • “Global multi-stakeholder endorsement of the MAFLD definition”
    Authors: N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, …
    Year: 2022
    Citations: 203
  • “Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa”
    Authors: G Shiha, K Alswat, M Al Khatry, AI Sharara, N Örmeci, I Waked, …
    Year: 2021
    Citations: 150
  • “Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug-resistant Salmonella typhi septicemia in children”
    Authors: NI Girgis, Y Sultan, O Hammad, Z Farid
    Year: 1995
    Citations: 81
  • “Changing Patterns of Acute Viral Hepatitis at a Major Urban Referral Center in Egypt”
    Authors: S Zakaria, R Fouad, O Shaker, S Zaki, A Hashem, SSE Kamary, G Esmat, …
    Year: 2007
    Citations: 74
  • “Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients”
    Authors: R Eletreby, W Elakel, M Said, M El Kassas, S Seif, T Elbaz, M El Raziky, …
    Year: 2017
    Citations: 70
  • “Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma”
    Authors: MH Elnaggar, AI Abushouk, AHE Hassan, HM Lamloum, A Benmelouka, …
    Year: 2021
    Citations: 52
  • “Knowledge, applicability, and barriers of telemedicine in Egypt: a national survey”
    Authors: M Alboraie, MA Allam, N Youssef, M Abdalgaber, F El-Raey, N Abdeen, …
    Year: 2021
    Citations: 47
  • “Radiofrequency ablation combined with percutaneous ethanol injection in patients with hepatocellular carcinoma”
    Authors: M Azab, S Zaki, AG El-Shetey, MF Abdel-Moty, NMG Alnoomani, …
    Year: 2011
    Citations: 42
  • “Ceftriaxone versus chloramphenicol for treatment of acute typhoid fever”
    Authors: OM Hammad, T Hifnawy, D Omran, MA El Tantawi, NI Girgis
    Year: 2011
    Citations: 42
  • “Comparison Between Insecticidal Activity of Lantana camara Extract and its Synthesized Nanoparticles Against Anopheline mosquitoes”
    Authors: N Abd El Hafiz Hassanain, M Shaapan, M Abd El Hafiz Hassanain, …
    Year: 2019
    Citations: 41
  • “Prevalence, risk factors and impacts of schistosomal and intestinal parasitic infections among rural school children in Sohag Governorate”
    Authors: HM El-Masry, YA Ahmed, AA Hassan, S Zaky, ES Abd-Allah, …
    Year: 2007
    Citations: 37
  • “Diagnostic significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p panel and ratios in hepatocellular carcinoma on top of liver cirrhosis in HCV-infected patients”
    Authors: MA Eldosoky, R Hammad, AA Elmadbouly, RB Aglan, SG AbdelHamid, …
    Year: 2023
    Citations: 33
  • “Egyptian recommendations for management of Helicobacter pylori infection: 2018 report”
    Authors: M Alboraie, W Elhossary, OA Aly, B Abbas, L Abdelsalam, D Ghaith, …
    Year: 2019
    Citations: 33
  • “Significance of glypican-3 in early detection of hepatocellular carcinoma in cirrhotic patients”
    Authors: AM Tahon, MZ El-Ghanam, S Zaky, TM Emran, AM Bersy, F El-Raey, E AZ, …
    Year: 2019
    Citations: 32

Jean-Christophe Rwigema | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Jean-Christophe Rwigema | Medicine and Dentistry | Best Researcher Award

Resident Physician at Endeavor Health, United States

Jean-Christophe N. Rwigema, MD, MPH, is a dedicated medical professional specializing in surgery, with a focus on foregut and bariatric surgery. He is currently a postdoctoral research fellow at NorthShore University Health System, where he engages in clinical research to advance surgical practices and improve patient outcomes. Dr. Rwigema earned his Doctor of Medicine and Master of Public Health from the Keck School of Medicine of USC, equipping him with a comprehensive understanding of both clinical medicine and public health challenges. His commitment to improving community health is evident in his involvement in various health initiatives, and he continues to shape the next generation of healthcare professionals through mentoring and leadership roles in medical education.

Professional Profile

Education

Dr. Rwigema received his medical degree from the Keck School of Medicine of the University of Southern California, where he also completed a Master of Public Health. His academic journey began at the University of California, Irvine, where he earned a Bachelor of Science in Biological Sciences. He further pursued postbaccalaureate training at the University of California, San Diego, in their School of Medicine. Currently, he is completing his residency in General Surgery at the University of Florida College of Medicine Jacksonville, anticipating graduation in June 2027. This diverse educational background, combining rigorous medical training with public health expertise, provides Dr. Rwigema with a unique perspective on patient care and healthcare systems.

Professional Experience

Dr. Rwigema’s professional experience encompasses various roles in clinical research and surgical practice. As a Surgical Research Fellow at NorthShore University Health System, he actively participates in clinical trials focused on foregut and bariatric surgery. He previously worked as a Medical Student Researcher at the Keck School of Medicine, where he assessed disparities in lung cancer incidence and the impact of electronic medical records on patient interactions. His leadership roles, including co-organizing the Firearm Violence Prevention Symposium and mentoring aspiring healthcare professionals, showcase his commitment to community health and education. These experiences highlight his strong foundation in both clinical practice and research, positioning him as a leader in the medical field.

Research Interests

Dr. Rwigema’s research interests lie at the intersection of surgical innovation and public health. His current focus on foregut and bariatric surgery aims to improve patient outcomes through evidence-based practices. He has contributed to several studies assessing esophageal motility disorders and evaluating the effectiveness of surgical interventions such as Toupet fundoplication. Additionally, his interest in health disparities, particularly among gender minority individuals, reflects his commitment to addressing inequities in healthcare access and treatment. Through his research, Dr. Rwigema aims to advance surgical methodologies and enhance the quality of care for diverse patient populations.

Awards and Honors

Dr. Rwigema has received recognition for his contributions to medical research and community health initiatives. His work has led to multiple peer-reviewed publications, with articles published in notable surgical journals. He has presented his research at prestigious conferences, including the Central Surgical Association and SAGES Annual Meeting, further establishing his reputation in the surgical community. His leadership and mentorship roles, such as coordinating events for the Student National Medical Association, demonstrate his commitment to promoting diversity in medicine. As he continues his journey in the medical field, Dr. Rwigema is poised to achieve further accolades and make significant contributions to surgical research and public health.

Conclusion

Dr. Jean-Christophe N. Rwigema is a highly qualified candidate for the Best Researcher Award due to his extensive and ongoing research in surgery, particularly foregut and bariatric surgery, with numerous publications and presentations that highlight his contributions. While he has demonstrated strong collaborative research and leadership skills, his profile could be further strengthened by more independent, focused research leadership and a clearer specialization. Overall, his academic and professional accomplishments, coupled with his promising career trajectory, make him a competitive candidate for the award.

Publication top noted

  • Using Impedance Planimetry (EndoFLIP) to Determine Ideal Distensibility Ranges for Esophageal Motility Disorders
    📄 Rwigema, J.-C.N., Kuchta, K., Anderson, D.J., … Hedberg, H.M., Ujiki, M.B.
    🗓️ 2024
    🔗 Surgery (United States), in press
  • Impact of Toupet Fundoplication with Bougie on Post-Operative Dysphagia and Quality of Life
    📄 Anderson, D.J., Kuchta, K., Joseph, S., … Hedberg, H.M., Ujiki, M.B., Rwigema, J.-C.N.
    🗓️ 2024
    🔗 Surgical Endoscopy, 38(9), pp. 5350–5355
  • Efficacy and Outcomes of Per Oral Plication of the (Neo)esophagus (POPE) for Impaired Emptying in Achalasia and Post-Esophagectomy Patients
    📄 Crafts, T.D., Seidel, H., Hedberg, H.M., … Ishii, S., Ujiki, M.B.
    🗓️ 2024
    🔗 Surgical Endoscopy, 38(9), pp. 5239–5245
  • Assessing Disparities in Lung Cancer Incidence for Gender Minority Individuals Using California Cancer Registry Data
    📄 Liu, L., Rwigema, J.-C.N., Song, Z., … Kim, S.E., David, E.A.
    🗓️ 2021
    🔗 Chest, 159(6), pp. 2491–2493